Bruker Corporation announced the introduction of its groundbreaking dissolution Dynamic Nuclear Polarization (d-DNP) Polarizer on April 2, 2025, at the 2025 Hyperpolarized Carbon-13 MRI Technology Development Workshop at UCSF. The first customer installation of this technology has been successfully completed at UCSF.
The d-DNP Polarizer enhances the sensitivity of Nuclear Magnetic Resonance (NMR) and Magnetic Resonance Imaging (MRI) by over 10,000-fold for 13C in solution samples. It achieves this by transferring polarization from electron spins to nuclear spins in a 7 Tesla polarizer magnet at temperatures below 1.4 Kelvin, accelerated by Bruker’s proprietary active cross-polarization technology.
This technology is particularly beneficial for in vivo studies of 13C-labelled metabolites, enabling real-time tracking of chemical conversion to downstream metabolites. It holds potential for improving cancer diagnostics and assessing treatment response in preclinical research, with additional customer installations planned in Europe and the US.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.